Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

Tremonton Archived • November 10, 2025 •

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses –

Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original

FB X ✉️

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!